Daily aspirin use 'reduces ovarian cancer risk by 20%'
2/10/2014
Previous research has suggested that aspirin may help to reduce the risk of breast cancer and melanoma. Now, new research from the National Institutes of Health suggests that women who take low-dose aspirin every day may reduce their risk of ovarian cancer by 20%.The findings were recently published in the Journal of the National Cancer Institute.
Leukemia: study of twin sisters leads to novel molecular discovery
2/10/2014
According to the National Cancer Institute, 2013 saw approximately 48,610 new cases of leukemia diagnosed in the US. Now, from analyzing the genomes of twin 3-year-old-sisters - one with and one without aggressive leukemia - researchers have discovered a new molecular target that could be used to treat deadly and recurring forms of the disease.
Clues to cancer pathogenesis found in cell-conditioned media
2/10/2014
Primary effusion lymphoma (PEL) is a rare B-cell neoplasm distinguished by its tendency to spread along the thin serous membranes that line body cavities without infiltrating or destroying nearby tissue.
New combined therapy proposed to treat cancer
2/10/2014
A large part of the effort dedicated to cancer research is directed towards the search for combinations of existing drugs - many of which have already been introduced into clinical practice - that permit higher overall survival rates and improvements in the quality of life of cancer patients.
New gene defect identified which causes a particular type of bone marrow failure
2/09/2014
The study, published in The American Journal of Human Genetics, detected and identified a new disease gene (ERCC6L2). In its normal form, the gene plays a key role in protecting DNA from damaging agents, but when the gene is mutated the cell is not able to protect itself in the normal way.
New gene defect identified which causes a particular type of bone marrow failure
2/09/2014
The study, published in The American Journal of Human Genetics, detected and identified a new disease gene (ERCC6L2). In its normal form, the gene plays a key role in protecting DNA from damaging agents, but when the gene is mutated the cell is not able to protect itself in the normal way.
Insights into network that plays crucial role in cell function and disease
2/08/2014
A new research paper from the labs of University of Notre Dame researchers Holly Goodson and Mark Alber helps resolve an ongoing debate about the assembly of a subcellular network that plays a critical role in cell function and disease.Goodson and her former postdoctoral fellow Kamlesh Gupta (now a senior scientist at W. M.
Intelligent redesign of cancer care delivery model guided by MD Anderson
2/08/2014
Quality leaders outline action plan for national oversight, collaboration and patient-centered approachesHow best to implement key recommendations recently identified by the Institute of Medicine (IOM) for the delivery of high-quality cancer care is the focus of two peer-reviewed articles from The University of Texas MD Anderson Cancer Center.
No childhood leukemia risk from power lines
2/07/2014
Children who spend their early years living near overhead power lines are not at greater risk of developing childhood leukemia, according to researchers at the University of Oxford in the UK, who report their findings in the British Journal of Cancer.In the UK, as in the US, leukemia accounts for around a third of all cancers diagnosed in children.
No childhood leukemia risk from power lines
2/07/2014
Children who spend their early years living near overhead power lines are not at greater risk of developing childhood leukemia, according to researchers at the University of Oxford in the UK, who report their findings in the British Journal of Cancer.In the UK, as in the US, leukemia accounts for around a third of all cancers diagnosed in children.